NYSE:GMED Globus Medical (GMED) Stock Price, News & Analysis $56.48 +0.79 (+1.41%) Closing price 03:59 PM EasternExtended Trading$56.74 +0.26 (+0.46%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Globus Medical Stock (NYSE:GMED) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Globus Medical alerts:Sign Up Key Stats Today's Range$55.33▼$56.5850-Day Range$52.60▼$62.9152-Week Range$51.79▼$94.93Volume1.71 million shsAverage Volume1.21 million shsMarket Capitalization$7.63 billionP/E Ratio17.35Dividend YieldN/APrice Target$87.64Consensus RatingModerate Buy Company Overview Globus Medical, Inc. (NYSE:GMED) is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes. In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room. The ExcelsiusGPS® robotic guidance system, for example, integrates real-time imaging with robotic arm technology to enable surgeons to perform complex procedures with greater accuracy. The company also offers an array of trauma and orthopaedic solutions, such as bone graft substitutes and joint reconstruction implants, to address a broad spectrum of musculoskeletal conditions. Globus Medical serves surgeons and patients across North America, Europe, Asia, Latin America and the Middle East through a combination of direct sales and distribution partnerships. Under the leadership of founder and Executive Chairman David C. Paul and President and Chief Executive Officer Glenn J. Shapiro, the company has built a global commercial infrastructure and invested in research and development to drive innovation. Its commitment to surgical education and customer support further reinforces its position in the competitive medical device landscape.AI Generated. May Contain Errors. Read More Globus Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks95th Percentile Overall ScoreGMED MarketRank™: Globus Medical scored higher than 95% of companies evaluated by MarketBeat, and ranked 64th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingGlobus Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.Upside PotentialGlobus Medical has a consensus price target of $87.64, representing about 55.1% upside from its current price of $56.49.Amount of Analyst CoverageGlobus Medical has only been the subject of 4 research reports in the past 90 days.Read more about Globus Medical's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth17.15% Earnings GrowthEarnings for Globus Medical are expected to grow by 17.15% in the coming year, from $3.44 to $4.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Globus Medical is 17.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.43.Price to Earnings Ratio vs. SectorThe P/E ratio of Globus Medical is 17.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.67.Price to Earnings Growth RatioGlobus Medical has a PEG Ratio of 1.52. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGlobus Medical has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Globus Medical's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.23% of the float of Globus Medical has been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Globus Medical has recently increased by 5.88%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGlobus Medical does not currently pay a dividend.Dividend GrowthGlobus Medical does not have a long track record of dividend growth. Sustainability and ESG4.1 / 5Environmental Score-0.93 Percentage of Shares Shorted5.23% of the float of Globus Medical has been sold short.Short Interest Ratio / Days to CoverGlobus Medical has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Globus Medical has recently increased by 5.88%, indicating that investor sentiment is decreasing significantly. News and Social Media2.1 / 5News Sentiment0.81 News SentimentGlobus Medical has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.02 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Globus Medical this week, compared to 14 articles on an average week.Search InterestOnly 4 people have searched for GMED on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows2 people have added Globus Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Globus Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $584,600.00 in company stock.Percentage Held by Insiders18.54% of the stock of Globus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions95.16% of the stock of Globus Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Globus Medical's insider trading history. Receive GMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GMED Stock News HeadlinesGlobus Medical (NYSE:GMED) Director Sells $584,600.00 in StockSeptember 17, 2025 | insidertrades.comGlobus Medical (NYSE:GMED) Lowered to "Hold" Rating by Wall Street ZenSeptember 28 at 2:05 AM | americanbankingnews.comWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.September 29 at 2:00 AM | SmartAsset (Ad)Globus Medical, Inc. (NYSE:GMED) Receives $87.64 Average PT from BrokeragesSeptember 22, 2025 | americanbankingnews.com1 Small-Cap Stock with Solid Fundamentals and 2 Facing HeadwindsSeptember 17, 2025 | finance.yahoo.comGlobus Medical (NYSE:GMED) shareholders have endured a 16% loss from investing in the stock a year agoSeptember 11, 2025 | finance.yahoo.comSpotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & Supplies - Specialty Stocks In Q2September 4, 2025 | msn.comGlobus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform RatingSeptember 2, 2025 | insidermonkey.comSee More Headlines GMED Stock Analysis - Frequently Asked Questions How have GMED shares performed this year? Globus Medical's stock was trading at $82.71 at the beginning of the year. Since then, GMED shares have decreased by 31.7% and is now trading at $56.4850. How were Globus Medical's earnings last quarter? Globus Medical, Inc. (NYSE:GMED) announced its quarterly earnings data on Thursday, August, 7th. The medical device company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.10. Globus Medical's revenue for the quarter was up 18.4% compared to the same quarter last year. Read the conference call transcript. Is Globus Medical buying back stock? Globus Medical's Board of Directors approved a stock buyback plan on Thursday, May 15th 2025, which authorizes the company to repurchase $500,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its shares are undervalued. How do I buy shares of Globus Medical? Shares of GMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Globus Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Globus Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET), Advanced Micro Devices (AMD) and ServiceNow (NOW). Company Calendar Last Earnings8/07/2025Today9/29/2025Next Earnings (Estimated)11/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryHealth Care Equipment Current SymbolNYSE:GMED CIK1237831 Webwww.globusmedical.com Phone(610) 930-1800Fax610-930-2042Employees5,300Year Founded2003Price Target and Rating Average Price Target for Globus Medical$87.64 High Price Target$115.00 Low Price Target$66.00 Potential Upside/Downside+55.5%Consensus RatingModerate Buy Rating Score (0-4)2.62 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)$2.60 Trailing P/E Ratio21.68 Forward P/E Ratio16.38 P/E Growth1.52Net Income$102.98 million Net Margins13.58% Pretax Margin14.22% Return on Equity10.65% Return on Assets8.86% Debt Debt-to-Equity RatioN/A Current Ratio4.07 Quick Ratio2.26 Sales & Book Value Annual Sales$2.52 billion Price / Sales3.02 Cash Flow$6.74 per share Price / Cash Flow8.36 Book Value$30.40 per share Price / Book1.85Miscellaneous Outstanding Shares135,060,000Free Float110,017,000Market Cap$7.61 billion OptionableOptionable Beta1.16 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NYSE:GMED) was last updated on 9/29/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.